Award
Delivery Order #75F40126F19003
Delivery Order for Human Induced Pluripotent Stem Cells to Support Biomedical Research
Buyer
Food and Drug Administration
Award Amount
$144,970.00
Ceiling
$144,970.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2027
Identifier
75F40126F19003
NAICS
325414
This award represents a delivery order contract issued under a broader indefinite delivery vehicle (IDV) to Fujifilm Irvine Scientific, Inc., a leader in providing advanced biotechnological products and services. The contract focuses on the purchase of human induced pluripotent stem cell-derived (hiPSC) cells, essential for cutting-edge biomedical research and therapeutic advancements. These hiPSC cells play a critical role in disease modeling, drug discovery, and regenerative medicine, thus significantly benefiting public health research initiatives. The scope of this delivery order involves supplying high-quality hiPSC cells to support ongoing scientific studies, ensuring researchers have access to consistent and reliable biological materials. Awarded through an established IDV following a competitive procurement process, this contract continues a sustained partnership with Fujifilm Irvine Scientific, building on their proven expertise in stem cell technology. The agreement covers a one-year performance period, commencing in the latter part of 2026 and extending through late 2027, reflecting a substantial commitment to advancing biomedical innovation during this timeframe.
Description
EO 14398 - PURCHASE OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED (HIPSC) CELLS.